Workflow
Policy Impact
icon
Search documents
Acadia Healthcare Company (NasdaqGS:ACHC) FY Conference Transcript
2026-03-10 17:02
Acadia Healthcare Company (NasdaqGS:ACHC) FY Conference Summary Company Overview - **Company**: Acadia Healthcare Company - **Industry**: Behavioral Health Services - **Event**: Barclays Global Healthcare Conference - **Date**: March 10, 2026 Key Points Leadership Changes - **CFO Todd Young** has been in the role for just over 4 months, with **Debbie** returning as CEO, bringing over 30 years of experience in behavioral health [3][4] - The leadership change has invigorated operations, with a focus on filling 3,000 new beds added across facilities [3][4] Financial Performance and Opportunities - **$200 million** embedded EBITDA opportunity exists from facilities opened in the last three years, with underperformance attributed to licensure delays and operational execution issues [4][5] - Current occupancy rates for new facilities are behind expectations, indicating a significant opportunity for profitability improvement [7][8] Growth Projections - **2026 guidance** anticipates approximately **4% growth** in same-store volume, driven by operational execution and expansion of existing facilities [8][9] - Demand for inpatient psychiatric services remains strong, with specialty business growth impacted by facility closures and New York Medicaid policy changes [10][11] Medicaid and Payer Dynamics - New York's policy change restricting out-of-state Medicaid care is expected to create a **$25 million-$30 million** EBITDA headwind in 2026 [19][21] - Increased scrutiny from payers regarding length of stay and denials has been noted, with a stable length of stay expected across the company [14][15] Staffing and Compliance - California's new staffing requirements are projected to result in a **$4 million** EBITDA headwind, with compliance efforts ongoing [23][24] - The company is focused on hiring higher-skilled nurses to meet these requirements without reducing occupancy [23][24] Claims and Safety Investments - A **$61 million** increase in PLGL expenses was reported, driven by a **186%** increase in claims [27][28] - Investments in safety and quality technology are being made to reduce incident risk and improve patient care [30] Capital Deployment and Cash Flow - CapEx is expected to decline by more than **$300 million** in 2026, with positive free cash flow anticipated [31][32] - Priorities for discretionary cash deployment include debt reduction and operational improvements rather than new capital expenditures [31][32] Outpatient Behavioral Opportunities - The company has a significant outpatient business through its CTC division, focusing on integrating outpatient care as part of a continuum of care rather than pursuing a standalone outpatient model [34] Additional Insights - The company is actively working to backfill facilities affected by policy changes and is optimistic about the potential reassessment of New York's Medicaid policy [21][22] - Continuous monitoring of claims and settlement costs is in place to manage financial expectations and mitigate risks [29][30]
X @The Economist
The Economist· 2025-10-30 02:00
Around 2bn birds were killed within two years of China’s “Four Pests” campaign during Mao’s Great Leap Forward. One working paper suggests that the policy inadvertently killed millions of people, too https://t.co/8qcZzQOrmj https://t.co/PzwA5ku698 ...
X @The Economist
The Economist· 2025-10-24 22:40
Around 2bn birds were killed within two years of China’s “Four Pests” campaign during Mao Zedong’s Great Leap Forward. One working paper suggests that the policy inadvertently killed millions of people, too https://t.co/ZKaIL0hNmz ...